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Proper remodeling of the endocardial cushions into thin ﬁbrous valves is essential for gestational pro-
gression and long-term function. This process involves dynamic interactions between resident cells and
their local environment, much of which is not understood. In this study, we show that deﬁciency of the
cell–cell adhesion protein cadherin-11 (Cad-11) results in signiﬁcant embryonic and perinatal lethality
primarily due to valve related cardiac dysfunction. While endocardial to mesenchymal transformation is
not abrogated, mesenchymal cells do not homogeneously cellularize the cushions. These cushions re-
main thickened with disorganized ECM, resulting in pronounced aortic valve insufﬁciency. Mice that
survive to adulthood maintain thickened and stenotic semilunar valves, but interestingly do not develop
calciﬁcation. Cad-11 / aortic valve leaﬂets contained reduced Sox9 activity, β1 integrin expression, and
RhoA-GTP activity, suggesting that remodeling defects are due to improper migration and/or cellular
contraction. Cad-11 deletion or siRNA knockdown reduced migration, eliminated collective migration,
and impaired 3D matrix compaction by aortic valve interstitial cells (VIC). Cad-11 depleted cells in culture
contained few ﬁlopodia, stress ﬁbers, or contact inhibited locomotion. Transfection of Cad-11 depleted
cells with constitutively active RhoA restored cell phenotypes. Together, these results identify cadherin-
11 mediated adhesive signaling for proper remodeling of the embryonic semilunar valves.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Heart valves are critical regulators of one-way blood ﬂow
through the heart. The embryonic heart grows nearly 100 fold
during embryonic development, developing similar increases in
ventricular chamber pressures that require continuous valve ac-
tion for gestational progression (Butcher et al., 2007b; Hu and
Clark, 1989; Keller et al., 1991). The valvular primordia originate
from the endocardium of the atrioventricular (AV) and outﬂow
tract (OFT) through a process of endocardial to mesenchymal
transformation (EMT). The new mesenchymal cells invade and
proliferate into an underlying gelatinous matrix called the cardiac
jelly, until a nearly homogenous cellularized mass is formed
(Moreno-Rodriguez et al., 1997). Well over 100 molecular agents
coordinate to govern EMT decisions and subsequent cushion for-
mation (Chakraborty et al., 2010; Eisenberg and Markwald, 1995;
Person et al., 2005; Townsend et al., 2011). Defects in the early
EMT process in valves are nearly uniformly lethal and unlikely to
be registered clinically (Bartman and Hove, 2005). However,.defects in the subsequent remodeling of the valvuloseptal appa-
ratus are the most common type of birth defect (affecting 1–2% of
all live births) and often requires intervention soon after birth
(Hoffman et al., 2004). Therefore, an understanding of these later
stage mechanisms is critically important for generating clinically
relevant intervention strategies.
After cardiac chamber septation, the globular AV and OFT
cushions condense and elongate into thin ﬁbrous leaﬂets. The
glycosaminoglycan rich extracellular matrix of the cushion is re-
modeled into highly organized stratiﬁed layers: the ventricularis
(or atrialis in the case of the AV valves) containing a laminate of
collagen and elastin, the spongiosa layer retaining mostly pro-
teoglycans, and the ﬁbrosa containing a mesh network of dense
collagen bundles (Aikawa et al., 2006; Hinton et al., 2006; Kruithof
et al., 2007). These layers work together for efﬁcient biomecha-
nical function of the leaﬂets, and consequently function is im-
paired when this matrix organization is compromised (Sacks and
Schoen, 2002). Simultaneous with this matrix remodeling, the
highly proliferative, immature, mesenchymal progenitors of the
cushion mature into a low-proliferative ﬁbroblast-like phenotype.
Far less is known about the mechanisms that control these later
remodeling events. Much attention has been given to identifying
upstream growth factors and downstream transcription factors
that are involved. A common phenotypic outcome resulting from a
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perplastic cushion with failure to condense or form quiescent ﬁ-
broblasts. This can result from mutations in TGFβ, VEGF, BMP, or
other pathways (Azhar et al., 2011; Galvin et al., 2000; Lee et al.,
2006), which suggests that all of these factors integrate, albeit
complexly, into cellular decisions to interact with and remodel
their microenvironment.
Cell-matrix adhesive interactions are governed largely by
complexes involving integrin receptors, while cell–cell adhesion is
governed primarily by cadherin containing complexes. We and
others have previously shown that both migration and matrix
condensation by AV cushion mesenchyme is adhesion dependent
(Butcher et al., 2007a; Ghatak et al., 2014; Mo and Lau, 2006). The
disruption of adherens junctions formed by endothelial/epithelial
cadherins, VE-cadherin, and E-cadherin are critical for the initia-
tion of EMT (Tatin et al., 2013). Cadherins are also present in
mesenchymal cells, and perform key roles coordinating collective
migration behaviors during embryonic development (Theveneau
et al., 2010).
Cadherin-11 (also Cad-11, cdh-11, OB-cadherin) is a mesench-
ymal cadherin that is expressed at the interface of tissues that
acquire ﬁbroblastic and osteoblastic phenotypes (Hoffmann and
Balling, 1995; Simonneau et al., 1995). Dysregulated Cad-11 ex-
pression contributes to inﬂammation, cartilage degradation, and
metastasis in diseases such as pulmonary ﬁbrosis, rheumatoid
arthritis, and multiple cancer types (Assefnia et al., 2014; Lee et al.,
2007; Schneider et al., 2012; Tomita et al., 2000). Cad-11 also plays
important roles in both cellular migration and differentiation in
development, in particular through mediating collective migration
and fate speciﬁcation in neural crest mesenchyme (Becker et al.,
2013; Borchers et al., 2001; Kashef et al., 2009). We recently
proﬁled the spatial and temporal expression of cadherin-11 (Cad-
11) during murine heart valve development (Zhou et al., 2013).
Cad-11 is expressed throughout the early cushion mesenchyme,
but its expression decreases and is redistributed in to the en-
dothelial cell layer during the later remodeling period as valves
condense and elongate into leaﬂets. These results motivated our
hypothesis that Cad-11 regulates the cellular architecture of the
endocardial cushion and participates in its subsequent remodeling
and phenotype maturation.
Here, we studied the effects of Cad-11 depletion on embryonic
valve formation and remodeling in vitro and in vivo. We establish
that Cad-11 is dispensable for EMT, but essential for proper cel-
lularization of the cushion. Cad-11 mutant semilunar valves re-
main thickened, do not form an organized extracellular matrix,
and result in signiﬁcant lethality secondary to insufﬁciency. Cad-11
deletion/knockdown disrupts valvular cell polarity, stress-ﬁber
formation, migration, and matrix compaction. We further found
that Cad-11 depletion reduces RhoA activity mediated ﬁlopodia
protrusion. Treatment of Cad-11 deﬁcient valve interstitial cells
with constitutively active RhoA restored all these cellular beha-
viors. Together, these results demonstrate that Cad-11 is essential
for establishing and coordinating embryonic valve mesenchymal
cell activities though RhoA to create mature ﬁbrous leaﬂets.2. Materials and methods
2.1. Mouse strains
Wildtype C57BL/6 and Cad-11 / mice (Taconic Biosciences)
were bred according to standard protocols. Cad-11 / mice were
donated by Michael Brenner and Masatoshi Takeichi (Kawaguchi
et al., 2001). All animal work was conducted following national and
international research guidelines. Full details of this study were re-
viewed and approved by the Cornell IACUC (protocol #2008-0011).2.2. Histology and immunoﬂuorescence labeling
Embryos and adult hearts were ﬁxed in 4% paraformaldehyde
overnight at 4 °C, then dehydrated through an ethanol series and
parafﬁn embedded and sectioned at 8 mm thickness. Following
dewaxing and rehydration, sections were stained with Hematox-
ylin and Eosin (H&E, cellular composition), Von Kossa (phosphate),
Alcian Blue (glycosaminoglycans), Picrosirius red (collagen), and
Verhoeff-Van Geison (elastin). TUNEL reaction was carried out as
described in Gould et al. (2012). For BrdU immunohistochemistry,
E16.5 embryos were sacriﬁced 2 h after IP injection of 1 mg of
BrdU reagent (BD Biosciences). Nuclear DNA was denatured in 2 N
hydrochloric acid for 10 min at 37 °C and quenched with hydrogen
peroxide for 10 min at room temperature. Sections were incubated
in primary antibodies (1:100) overnight at 4 °C, and then in sec-
ondary antibodies (1:300) for 1 h at a room temperature. 3,30-
Diaminobenzidine (DAB) was used as a chromogen. The percent of
positive cells was determined by normalizing to the total cell
number for both TUNEL and BrdU staining assays. Relative cushion
area was calculated by taking the largest cushion area from serial
sections, and normalizing to wild type cushion size at E11.5. Cell
fraction vs. depth fraction was determined by counting the num-
ber of cells at serial distances away from the myocardial edge of
the cushion, and normalizing to total cell number and cushion size
at E18.5. Valve thickness was measured using the widest thickness
of a valve leaﬂet from serial sections at E18.5. To measure stain
intensity for histological stainings, ﬁrst the ImageJ plugin Color
Deconvolution was used for the appropriate stain, then intensity
was measured and normalized to a tissue control portion of the
section, such as bone for Alcian Blue or arterial wall for Verhoeff-
Van Geison stains. Calciﬁcation density was determined by cal-
culating the size of any lesions present relative to the valve
leaﬂet size, and normalizing to lesion percentages in wild type
valve leaﬂets. Additional sections were processed for im-
munohistochemistry. For immunodetection, 10 mM citrate buffer
was used for antigen retrieval, and sections were blocked with 10%
goat serum before primary antibodies (1:100 dilution) were used
against Sox9 (rabbit, Abcam), vimentin (mouse, Invitrogen), alpha-
smooth muscle actin (mouse, Sigma), Active RhoA-GTP (mouse,
NewEast Biosciences), and β1 integrin (mouse, BioGenex). Fluor-
escence-conjugated Alexa Fluor 488 goat anti-rabbit and Alexa
Fluor 568 goat anti-mouse secondary antibodies (Invitrogen, 1:200
dilution) were used according to the primary antibody species.
Sections were nuclei counterstained with DRAQ5 (Abcam, 1:1000
dilution). Signals were detected and images were collected with
Zeiss 710 confocal microscopy (Cornell University Life Sciences
Core Laboratories Center). Nuclei (blue) were counted manually to
determine cell number, and normalized to the size of the leaﬂet.
The widest valve sections were used for these calculations to en-
sure consistency. Immunoreactivity of proteins stained in tissue
sections was measured using ImageJ (NIH, Bethesda, MD) as de-
monstrated previously, with expression normalized to valve size
and immunoﬂuorescence intensity of wild type valve regions
(Farrar and Butcher, 2013; Mahler et al., 2013). Sox9 nuclear co-
localization was measured using NIH ImageJ software. Green
(Sox9) and far-red (nuclei) channels were each thresholded and
co-localized regions were measured using the ImageJ plugin Co-
localization. Fluorescence intensity of colocalized Sox9 was taken
as a percentage of overall Sox9 ﬂuorescence intensity.
2.3. Doppler ultrasound transthoracic echocardiography
Mice were bred according to standard protocol, and plug
checks were used to determine day of pregnancy. Embryos and
mice were bred to desired stage, and the mice were anesthetized
using 1.5% isoﬂurane. Abdomens of pregnant females and chests of
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attenuation. Heart rate and core temperature were continuously
monitored throughout the procedure. 2D cross-sectional and
Doppler transthoracic echocardiography was performed using a
Visual Sonics Vevo 2100 system (Cornell University Life Sciences
Core Laboratories Center).
2.4. Genetic modiﬁcation of cells
Porcine aortic valve interstitial cells (PAVICs) were cultured in
Dulbecco's modiﬁed Eagle's medium (Invitrogen, Carlsbad, CA)
supplemented with 5% fetal bovine serum (Gibco, Grand Island,
NY) at 37 °C and 5% CO2 as previously described (Butcher and
Nerem, 2004). PAVICs were used between passages 5–8. PAVICs or
primary culture chick interstitial valve cells were transfected with
plasmids using the Neon Transfection system (Invitrogen) for one
pulse at 1600 V for 20 ms. Cells were transfected with three
scrambled control plasmids, three Cad-11 short interfering RNA
(siRNA) plasmids, or three Cad-11 siRNA plasmids and a con-
stitutively active RhoA (CA-RhoA) plasmid (pRK5-myc-RhoA-Q63L
was a gift from Gary Bokoch, Addgene plasmid # 12964) (Table
S1). RNA was extracted using the RNeasy Mini Kit (Qiagen, Va-
lencia, CA) and reverse transcribed into cDNA using the Super-
Script III Reverse Transcriptase kit (Invitrogen) according to the
manufacturer's instructions. Gene expression and Cad-11 knock-
down was conﬁrmed using real-time PCR (qPCR) with custom
primers (Table S2) and SYBR Green PCR master mix. Transfected
cells were seeded on autoclaved glass slides and cultured for 48 h.
They were subsequently ﬁxed with 4% paraformaldehyde at room
temperature, permeabilzed with 0.2% Triton-X, and blocked with
10% goat serum before staining with phalloidin conjugated with
Alexa Fluor 488 (F-actin, Invitrogen, 1:40 dilution) and DRAQ5.
2.5. Valve cell explant migration, compaction, and morphology
HH24 AV cushion or HH40 aortic valve leaﬂet cells were iso-
lated from chick hearts and cultured before use in migration and
compaction assays as previously described (Butcher et al., 2007a).
For migration, HH24 chick interstitial valve cells were collected in
a hanging drop culture before seeding in a 1% collagen gel. Mi-
gration area was measured by outlining the region of maximum
migration in all directions. HH40 chick interstitial valve cells were
seeded within a 1% collagen gel at 400,000 cells/ml and gels were
allowed to compact for 7 days. To examine migration and cell
morphology, Cad-11  / and wildtype mouse aortic valve inter-
stitial cells were isolated from hearts and explanted on 1% collagen
hydrogels. Cells were allowed to migrate for 24 h before being
ﬁxed with 4% paraformaldehyde at room temperature, permeabi-
lized with 0.2% Triton-X, and blocked with 10% goat serum before
staining with phalloidin (F-actin) conjugated with Alexa Fluor 488
(1:40 dilution, Invitrogen). To study morphological differences,
cells were allowed to adhere for 48 h before being ﬁxed with 4%
paraformaldehyde at room temperature, permeabilzed with 0.2%
Triton-X, and blocked with 10% goat serum before staining with
Active RhoA primary antibody and Alexa Fluor 488 secondary
antibody or phalloidin conjugated with Alexa Fluor 488 (F-actin,
Invitrogen, 1:40 dilution). Genetically modiﬁed PAVICs were cul-
tured on glass slides immediately after siRNA treatment for 48 h
and stained with phalloidin. Protrusion length and number were
manually counted and measured from tip to base. Similarly, the
number of cells with stress ﬁbers were manually counted and
taken as a percentage of total number of cells in a given image
area. Overlapping cells were categorized as cells that were both
touching and on top of other cells, normalized to total cell number
in a given image area.2.6. Statistical analyses
All data are reported as means with at least three independent
experiments per treatment, and error bars represent standard er-
ror of the mean. Statistical signiﬁcance was determined using the
Student's t-test or Chi-squared analysis. Differences between
means were considered signiﬁcant at po0.05.3. Results
3.1. Cad-11 deletion results in embryonic and perinatal lethality
Previously, our group showed that Cad-11 expression is spa-
tially and temporally restricted to developing heart valves (Zhou
et al., 2013). Though Cad-11  / mice are viable, they have small
litters at birth and the Cad-11  / mice are smaller in size than
their siblings. We therefore suspected the existence of a cardio-
vascular defect. We acquired and genotyped litters between E10.5
and the perinatal period (P2). Wildtype mice were present at ex-
pected Mendelian ratios throughout development. Homozygous
Cad-11 null (Cad-11  /) mice exhibited signiﬁcant lethality both
at E12.5 and at birth (Table 1, p¼0.02, 1.00E7, respectively). The
most dramatic Cad-11  / lethality occurred between E14.5 (68%
of expected survival) and birth (24% of expected survival,
p¼1.00E7), suggesting that Cad-11 plays a functional role during
these stages of development. We also found evidence of liver he-
morrhaging in E12.5 mice, which is consistent with pronounced
cardiac dysfunction (Sakata et al., 2002) (Fig. S1).
3.2. Cad-11  / embryos exhibit structural defects in valve mor-
phogenesis in early and late gestation
Histological analysis revealed that the atrioventricular en-
docardial cushions at E11.5 were approximately 36% smaller than
wildtype controls (Cad-11 þ /þ), while the outﬂow tract cushions
were similar in size (Fig. 1A and B). Interestingly, Cad-11  / AV
cushions contained an uneven cellular distribution, with 74% more
cells concentrated toward the endocardial surface of the atrio-
ventricular and outﬂow tract cushions. These results suggest that
Cad-11 deletion does not disrupt endocardial to mesenchymal
transformation, but rather impairs the subsequent migration of
these mesenchymal cells through the cushions (Fig. 1C, Fig. S1G).
Interestingly, by stage E18.5, the semilunar valves of Cad-11  /
hearts were signiﬁcantly thickened (465%) compared with those
of wildtype controls, while the atrioventricular valves were similar
in size and shape (Fig. 1A and D). These results suggest that post-
EMT remodeling of the valves derived from the outﬂow tract
cushion may be more affected by the loss of Cad-11, as the valves
that developed from the misaligned atrioventricular cushions
were able to recover and develop properly. Additionally, there are
post-EMT remodeling contributions from multiple cell types in the
outﬂow tract that are absent from the atrioventricular tract, such
as neural crest and anterior heart ﬁeld mesenchyme (Lin et al.,
2012), which may also be affected by loss of Cad-11. To assess the
consequence of the dysmorphic aortic valve on cardiac function,
Doppler in utero echocardiography was performed on the aortic
valve of E17.5 embryos. Cad-11 / aortic valves exhibit signiﬁcant
regurgitant ﬂow, averaging 47% of forward ﬂow (Fig. 2A). Together,
these results identify that Cad-11 is required for proper functional
remodeling of the semilunar valves. Although pulmonary valve
morphology was also affected, we did not further investigate it at
this time as the aortic valve is of greater clinical signiﬁcance given
its role in mediating cardiac output and is far likelier to contribute
to embryonic and post-natal lethality.
Table 1
Loss of Cad-11 signiﬁcantly impairs embryonic survival. Cad-11 þ / mice were
crossed to generate litters with mixed genotypes. The resulting number of each
genotype is shown with the corresponding percentage given in parentheses. At all
stages, the expected percentage is the Mendelian ratio of 25%/50%/25%. E desig-
nates embryonic day. p-Values calculated by chi-squared analysis at stage E12.5 and
at birth are statistically signiﬁcant, suggesting that it is just prior to these points the
embryos are unable to survive.
Cad11 þ /þ Cad11 þ / Cad11 / p-Value
E10.5 20 (29%) 31 (46%) 17 (25%) 0.67
E12.5 20 (40%) 17 (34%) 13 (26%) 0.02
E14.5 5 (17%) 19 (66%) 5 (17%) 0.24
Birth 56 (39%) 77 (54%) 9 (6%) 1.00E7
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fetal aortic valve leaﬂets
The structural anomalies in aortic valves of Cad-11 / mice
suggested defects in cellularization and/or matrix remodeling.
We ﬁrst assessed proliferation and apoptosis during late stage
aortic valve remodeling (E16.5). Mutant valves exhibited no
differences in cell proliferation as compared to control valves,
and there were very few apoptotic cells in either control or
mutant valve regions at this stage (Fig. S1). We nextFig. 1. Deletion of Cad-11 causes atrioventricular cushion defects at E11.5 and semilunar
than control at E11.5. Cad-11 null aortic and pulmonary valve leaﬂets are larger than con
null and control mice at E18.5. (Scale bar¼0.1 mm) (B) Quantiﬁcation of AV cushion sizes
within the atrioventricular cushion at E11.5, with more cells closer to the endotheli
(D) Quantiﬁcation of heart valve leaﬂet thickness at E18. 5 (n¼6, po0.05). AVC¼atriov
atrium; RV¼right ventricle; LA¼ left atrium; LV¼ left ventricle; Arrows indicate valve lecharacterized the extracellular matrix composition of late stage
aortic valve cusps in Cad-11 / embryos. Cad-11  / aortic
valves express signiﬁcantly lower levels of glycosaminoglycans
(GAGs) than controls (Fig. 2B and C). No discernable changes in
elastin or collagen content were observed in comparison to
controls (Fig. S2). We then proﬁled the expression of Sox9, a
transcription factor important for valvulogenesis and known to
stimulate glycosaminoglycan synthesis (Lincoln et al., 2007).
E18.5 Cad-11 þ /þ aortic valves express Sox9 prominently (cy-
toplasmic and nuclear) in the endocardium and the VIC in close
proximity. In E18.5 Cad-11  / aortic valves, Sox9 expression
was markedly decreased and rarely nuclear (27.6 þ / 3.5% vs.
11.8 þ / 3.2%, po0.05, Fig. 2D and E). These results suggest that
Cad-11 affects the cellular patterning and subsequent extra-
cellular matrix remodeling of the aortic valve.
3.4. Cad-11 knockdown decreases avian endocardial migration and
compaction
To dissect the cellular mechanisms underlying the endocardial
cushion and valve defects with Cad-11 deﬁciency, we applied
siRNA knockdown of Cad-11 to primary isolated chick aortic valve
(AoV) cells, consistently achieving 465% knockdown (Fig. 3A). To
evaluate the role of Cad-11 on AoV mesenchymal cell migration,
Cad-11 siRNA and scrambled siRNA control treated HH24 AoVvalve defects at E18.5 in mice. (A) Cad-11 null atrioventricular cushions are smaller
trol leaﬂets but tricuspid and mitral valve leaﬂets are similarly sized in both cad-11
at E11.5 (n¼6, po0.05). (C) Cad-11 null valves have an uneven distribution of cells
al edge of the cushion, (n¼7, po0.05 for KO depth, p40.05 for WT cushions).
entricular canal; OFT¼outﬂow tract; Ao¼aorta; PA¼pulmonary artery; RA¼right
aﬂets.
Fig. 2. Cad-11 null embryos have reduced GAGs and nuclear SOX9 in aortic valve leaﬂets at E18.5, and display embryonic valvular reguritation. (A) Echocardiography using
pulse-wave Doppler ultrasound shows that defective valve morphology causes regurgitation of blood ﬂow through the aortic valve in late stages of embryonic development,
suggesting a functional deﬁciency for lethality. Regurgitation is characterized by negative ﬂow velocity (white arrows), which is not present in wild type embryos. (B, C)
Alcian blue staining shows decreased GAGs in Cad-11 null mouse aortic valves as compared to control valves at E18.5. Boxed regions are positive Alcian blue staining in bones
of Cad-11 null and control mice (n¼3, *po0.05). Scale bar¼100 mm (D, E) SOX9 is more highly colocalized with nuclei in wild type mice suggesting it is active as opposed to
Cad-11 null mice, where it is expressed mostly in the cytoplasm (n¼6, *po0.01) Scale bar¼25 mm.
Fig. 3. (A) Quantiﬁcation of Cad-11 mRNA expression in chick HH24 AV cushions conﬁrms siRNA knockdown efﬁciency. Knockdown of Cad-11 impairs cell migration of
embryonic cushion mesenchyme and impedes ECM compaction of fetal valve mesenchyme. (B) Chick HH24 AV cushions transfected with Cad-11 siRNA plasmids migrate less
compared to scramble controls after 24 h and quantiﬁcation of cushion cell migration size at HH24 (n¼4, po0.01). (C) Cad-11 knocked down aortic valve interstitial cells
compact less than control cells after 7 days of culture at HH40 and quantiﬁcation of aortic valve interstitial cell matrix condensation at HH40. (n¼4, po0.05).
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Fig. 4. Cad-11 null mouse valve cells have longer and fewer protrusions, express less active RhoA and migrate less in collagen hydrogels. (A, B) Cad-11 null cells (B) show
reduced migration in collagen hydrogels compared to control cells (A). F-actin staining (green) shows Cad-11 null cells have different cell protrusion morphology at the
migrating edges and that cells are unable to detach and migrate away from the initial condensed hanging drop culture, whereas control cells are able to migrate as whole
cells (white arrows). (C) Quantiﬁcation of Cad-11 null valve interstitial cell migration area. (n¼4, *po0.05). (D, E) Cad-11 null cells (E) have less active RhoA compared to
control cells (D) at the edges, shown as ﬂuorescence intensity scaled 0 to 255. Scale bar¼50 mm (F) Quantiﬁcation of cell protrusion numbers of wildtype and Cad-11 null
aortic valve interstitial cells (n¼20, *po0.05). (G) Quantiﬁcation of cell protrusion lengths of wildtype and Cad-11 null aortic valve interstitial cells (n¼20, *po0.05).
C.J. Bowen et al. / Developmental Biology 407 (2015) 145–157150mesenchymal cells were aggregated by hanging drop and placed
on top of a collagen I gel. Cad-11 siRNA treated AoV mesenchyme
migrated 38% less than cells control cells (po0.05, Fig. 3B).
These results were also repeated with murine aortic valve inter-
stitial cells from Cad-11 WT and Cad-11 / mice (Fig. 4). As in the
embryonic condition, Cad-11 deﬁcient VIC migrated roughly half
the distance of the WT cells (Fig. 4A–C). Interestingly, while nor-
mal VIC exhibited collective migration away from the central cell
mass, while Cad-11 knockdown cells were unable to separate away
(Fig. 4A vs. B). Next, we assessed the affect of Cad-11 in a model of
cellular traction force mediated extracellular matrix compaction
(Grinnell et al., 1999). Primary isolated HH40 stage chick aortic
valve interstitial cells were treated with either scrambled control
or siRNA against Cad-11 and embedded in a free ﬂoating 1% col-
lagen gel as described previously (Richards et al., 2013). Cad-11
siRNA-treated cells compacted 47% less (Fig. 3C, 24.5% vs. 16.7%,
po0.05). Together, these results suggest that Cad-11 deﬁciency
affects valve mesenchymal/interstitial cell migration and traction
force generation.3.5. Cad-11 deﬁciency results in persistent immaturity of fetal aortic
valve interstitial cells
We next proﬁled a panel of proteins involved with cell migra-
tion and contractile phenotype (Fig. 5). Vimentin is a marker of
mature quiescent ﬁbroblast phenotype, while alpha-smooth
muscle actin (αSMA) is expressed in more immature mesenchymal
cells (Butcher et al., 2007a). RhoA activity is involved in adhesion
based signaling, and is critical for cell migration and traction force
generation (Reffay et al., 2014). Traction forces are communicated
to the extracellular matrix via integrins, of which the β1 compo-
nent is commonly employed (Rahmouni et al., 2013). Im-
munohistochemical analysis determined that E18.5 wildtype aor-
tic valves express vimentin, GTP-bound active RhoA (GTP-RhoA),
and β1-integrin robustly, but with low levels of αSMA (Fig. 5A-D,
I). Cad-11 / aortic valves however had 60–70% decreased vi-
mentin, and further reduced active RhoA and β1 integrin expres-
sion by 3.0 and 2.5 fold, respectively. Interestingly, αSMA protein
expression increased 2.4þ/0.2 fold, but was restricted to the
endothelial edge of the valve leaﬂet (Fig. 5E–I). Together, these
Fig. 5. Cad-11 deﬁciency results in persistent immaturity of fetal aortic valve interstitial cells. (A, C, D) Vimentin, GTP-RhoA, and β1 Integrin are all highly expressed in E18.5
Cad-11 þ /þ aortic valves. (E, G, H) There is little to no expression of these molecules in Cad-11 / valve cells. (B, F) aSMA expression is much higher in Cad-11  / cells as
compared to control, but is concentrated at the endothelial edges of the valve leaﬂets. (I): Quantiﬁcation of protein expression of wildtype and Cad-11 null aortic valves
(nZ3, *po5E3, **po5E4) Scale bar¼25 μm.
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valve mesenchymal phenotype in fetal aortic valves.
3.6. Cad-11 controls cell polarity and collective migration in aortic
valve interstitial cells through RhoA
We further examined the migration ability of Cad-11 deﬁcient
cells in embedded spheroid culture (Duan et al., 2013). As pre-
viously mentioned, wildtype valve mesenchyme exhibited collec-
tive cell migration phenotype, with clusters of cells migrating to-
gether away from the central cell mass. In contrast, Cad-11  /
cells exhibited no collective behavior (Fig. 4A vs. B, arrows), and
were unable to migrate as far as controls (Fig. 4C). Cad-11  / cells
extended single long processes radially outward from the cell mass
in 3D culture, while wildtype cells displayed multiple ﬁlopodia
(Fig. 4A and B). We next quantiﬁed ﬁlopodia extension and stress
ﬁber formation characteristics of the primary VIC from murine
Cad-11 wild type and null aortic valve interstitial cells in culture.
While Cad-11 þ /þ cells exhibit many protrusions in many direc-
tions away from the cell body, Cad-11  / cells exhibit only 2–3
very long protrusions at the polar ends of the highly elongated cell
(Fig. 4D–G). We then compared the activity of RhoA (GTP-bound)
in both cell types. We found robust RhoA activity in the Cad- 11þ /þ cells, with highest activity (determined by ﬂuorescence in-
tensity) within the ﬁlopodia. However, Cad-11 / cells expressed
much less active RhoA, with barely any activity within ﬁlopodia
(Fig. 4D and E). These ﬁndings suggested that RhoA activation
during cell migration lies downstream of Cad-11. In 2D, Cad-11
deﬁcient cells expressed signiﬁcantly fewer stress ﬁbers in com-
parison to controls, supporting that Cad-11 is important for di-
rectional migration and cell traction force generation (Fig. 6A and
B). We thus hypothesized that restoring RhoA activity would res-
cue cellular activities caused by Cad-11 deﬁciency. Porcine aortic
valve interstitial cells (PAVIC) were thus treated with either
scrambled control, Cad-11 siRNA, or Cad-11 siRNAþCA-RhoA and
subjected to the same morphology experiments. Similar to mouse
valve interstitial cells and fetal chick valve mesenchyme, we ob-
served fewer and longer protrusions in Cad-11 knockdown PAVIC
compared to scrambled control cells (Fig. 6A–E). Cad-11 deﬁciency
also increased the amount of cellular overlap, supporting that Cad-
11 also controls contact inhibited locomotion (Fig. 6A–C and G).
Induced expression of GTP-RhoA (via CA-RhoA transfection) in-
creased cell protrusions, and decreased protrusion length (Fig. 6C
and D). These cells also re-expressed stress ﬁbers (arrows) and
contact inhibited locomotion. Cad-11 siRNA treatment resulted in
lower vimentin, RhoA, SOX9, and aggrecan gene expression, but
Fig. 6. Rescue of Cad-11 knockdown phenotype with CA-RhoA stained with F-actin. (A, B) Control PAVICs have about 4.5 protrusions per cell and a protrusion length of about
20 μm while Cad-11 knockdown PAVIC have fewer protrusions per cell, fewer stress ﬁbers, and a much longer protrusion length. (C) Cad-11 knockdownþCA-RhoA PAVIC
have similar phenotypes to the control PAVICs. (nZ20, *po0.005, **po1E20). Scale bar¼50 μm (D–F) Re-expression of RhoA restores cell phenotypes and stress ﬁber
formation (n¼4 groups of cells, *po0.05), white arrows indicate stress ﬁber formation in control and siRNA/CA-RhoA treated cells and absence of stress ﬁber formation in
siRNA-only treated cells. (G) Cad-11 null cells have a greater percentage of overlapping cells compared to control and rescue cells (n¼4 groups of cells, *po0.05,
**po0.0005).
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at the mRNA level (Fig. S3). These results further support that
RhoA activity is downstream of Cad-11 and is required for VIC ﬁ-
lopodia extension, migration, and traction force generation.
3.7. Adult Cad-11  / mice survivors have persistently thickened
aortic valves and reduced RhoA activity, but do not calcify
Given that homozygous deletion of Cad-11 produces some
survivors, we examined the long-term consequences of Cad-11
deﬁciency on aortic valve structure and function in vivo. 10 month
adult Cad-11  / aortic valves were 3.3 þ / 0.1 fold thicker than
wildtype valves (Fig. 7A and B), establishing that morphological
defects due to loss of Cad-11 persist postnatally into adulthood.Adult Cad-11  / aortic valves contained more cells than wildtype
valves, but had no differences in cell density (Fig. 7D and H). We
did not ﬁnd differences in proliferation or apoptosis (as a per-
centage of total cells), supporting that any hypercellularization is
not due to an increased cell density, but rather compensatory cell
proliferation to accommodate the increased valve size (Fig. S1).
Thickened valve leaﬂets are typically associated with calciﬁc aortic
valve disease, and we previously showed that Cad-11 expression is
highly correlated with calciﬁc valve disease in mice and humans
(Zhou et al., 2013). We therefore analyzed calciﬁcation in Cad-11
þ /þ vs. Cad-11  / aortic valves. We found a few small Von Kossa
positive phosphate lesions in 10-month WT mice (Fig. 7E, arrows),
which was anticipated from previous reports (Tanaka et al., 2005).
However, we found no detectable staining in Cad-11 / valves
Fig. 7. Defects due to loss of cadherin-11 persist throughout adulthood. (A–D, H) Cad-11 / aortic valve leaﬂets (B) are signiﬁcantly thicker than Cad-11 þ /þ leaﬂets (A)
(n¼5, ***po1E4). Cad-11 / valves have similar cell density to Cad-11 þ /þ , but contain more cells (n¼4, ***po1E4). (E–G) Calciﬁcation of 10 month old adult valve
leaﬂets does not occur with loss of cadherin-11 (F) but does occur minimally in Cad-11 þ /þ leaﬂets (E) (n¼3, **po0.001) Scale bar¼0.2 mm (I–K) Cad-11  / mice have
increased maximum ejection velocity through the aortic valve compared to Cad-11 þ /þ mice at 10 months (n¼3, *po0.05).
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sistent with our previous studies associating elevated Cad-11 with
aortic valve calciﬁcation. Interestingly, Pulse wave Doppler ultra-
sound revealed that Cad-11 / adults had elevated ejection ve-
locity through the aortic valve, indicating hemodynamically re-
levant aortic valve stenosis as a result of thickened valves without
evidence of pathological extracellular matrix remodeling (Fig. 7I–
K). These results suggest that a loss of Cad-11 in adulthood could
be protective against pathological remodeling and stenosis, how-
ever residual effects of earlier valve deformations still cause he-
modynamically relevant disease. Cad-11  / leaﬂets expressed
more extracellular matrix than wildtype controls, but histological
analysis revealed no differences in relative amounts of glycosa-
minoglycans, collagen, or elastin (Figs. 8A, B and S2). In contrast to
fetal valves, nuclear expression of SOX9 was similar in both Cad-
11 þ /þ and Cad-11 / aortic valves in 10-month-old adult mice
(Fig. 8A–D). RhoA activity in 10-month old valves was elevated in
comparison to the fetal stage, but GTP-RhoA remained sig-
niﬁcantly decreased in the Cad-11 / valve leaﬂets (Fig. 8E and F).
These ﬁndings support that adult Cad-11 deﬁcient aortic valves
remain pathologically thickened and functionally stenotic, but
resistant to calciﬁcation.4. Discussion
Long-term efﬁcient cardiac performance requires that the heart
valves consistently restrict retrograde blood ﬂow while posing
near negligible resistance to forward ﬂow. This diode-like function
becomes progressively disrupted during disease pathogenesis,
leading to stenosis and regurgitation. It is increasingly more ap-
preciated that the same molecular mechanisms that participate in
the formation of heart valves are also reactivated during disease, in
particular calciﬁcation of the aortic valve (Wirrig and Yutzey,
2011). However, the mechanisms by which cells interact with their
tissue environment during these remodeling processes are less
understood. We previously identiﬁed the cell–cell adhesion pro-
tein cadherin-11 as uniquely expressed in aortic valve en-
dothelium (Butcher et al., 2006). More recently, we and others
determined that differential expression of Cad-11 at various stages
of valvulogenesis and during postnatal disease suggests that Cad-
11 is important for aortic valve tissue formation and remodeling
(Hutcheson et al., 2013; Zhou et al., 2013). In this study, we
identiﬁed how Cad-11 coordinates cellular activities during em-
bryonic valve formation and in postnatal valve homeostasis. We
determined that in Cad-11  / embryos, initial EMT does occur,
however the migrating cells remain close to the endocardium and
do not populate the cushions evenly. Post-EMT valve remodeling is
Fig. 8. Cad-11 null mice and wildtype mice have no differences in GAGs in aortic valve leaﬂets at 10 months. (A, B) Alcian blue staining shows no differences in GAG intensity
in Cad-11 null mouse aortic valves compared to control valves (n¼4, p¼0.46). Scale bar¼100 μm (C, D) SOX9 is equally colocalized with nuclei in both wildtype and Cad-11
null mice, suggesting there exists a compensatory mechanism involving SOX9 that restores GAG production. There were no differences in whole valve SOX9 expression
(graph not shown), (n¼4, p¼0.50). Scale bar¼25 μm (E, F) Postnatal active RhoA deﬁciency for Cad-11 null mice persists into adulthood. (n¼4, *po1E5) Scale bar¼25 μm.
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types in the heart as well, which also contribute to post-EMT valve
remodeling. Additionally, early embryonic cushions have regions
of hypercellularity (immediately subendothelial) and regions of
hypocellularity (near the myocardial border), and this hetero-
geneous cell density likely contributed to downstream mal-
formation and poor remodeling. Most mice die between E14.5 and
birth with severely thickened semilunar valve leaﬂets, however
those that survive are able to compensate to develop sufﬁciently
functional valves but with a consequence of chronic deﬁciency in
remodeling. Cad-11 depleted valve cells were unable to migrate
collectively, exhibited markedly impaired ﬁlopodia extension, and
limited stress ﬁber formation. Cad-11 loss was associated with
reduced RhoA activity regardless of age of the tissue. RhoA activity
restoration however was sufﬁcient to rescue stress ﬁber formation,
ﬁlipodia extension, and phenotypic gene expression. These ﬁnd-
ings elevate the role of mesenchymal cell–cell adhesive signaling
for proper heart valve formation and homeostatic remodeling.
After endocardial to mesenchymal transformation, embryonic
valvular progenitors migrate away from the endocardial surface
and invade the cardiac jelly space to create the endocardial
cushions (Kinsella and Fitzharris, 1980). This process occurs over
an approximately 72-h period in the chick and the mouse. Primary
migrating mesenchyme secrete proteoglycans that promote en-
docardial detachment and enable paths for trailing cells to follow
(Markwald et al., 1981). Though spatial and temporal asymmetries
exist in the distribution of mesenchyme within the cushions, cel-
lularization largely resembles a front of collectively migrating cells
that progresses towards the myocardial border (Bernanke andMarkwald, 1979, 1984; Moreno-Rodriguez et al., 1997). Directional
collective cell migration is essential for multiple morphogenic
events, including neural crest migration and speciﬁcation to cra-
niofacial tissues (Borchers et al., 2001). Most EMT derived me-
senchymal cells maintain epithelial cell–cell adhesion molecules
transiently at their surface, suggesting that they maintain some
ability to interact with their neighbors, which may initiate col-
lective migratory behavior (Theveneau and Mayor, 2013). Me-
senchymal cells also express cadherins, including N-cadherin and
Cadherin-11, that form cadherin-based adherens junctions (The-
veneau et al., 2010). Our ﬁndings of restricted migration of me-
senchymal progenitors from the endocardial boundary in vivo
combined with the lack of contact inhibited locomotion and col-
lective migration in vitro supports that these mesenchymal pro-
genitors require Cad-11 to regulate intercellular communication
and migration guidance during this process.
Cadherin signaling regulates cell protrusion formation and
functions upstream of small GTPases CDC42, RAC1, and RhoA
(Barth et al., 2009; Borghi et al., 2010; Maruthamuthu et al., 2010).
GTPase activity is highly speciﬁc and spatially localized within the
cell. For example, Rac1 controls leading edge ﬁlopodia extension
and polarity generation, while RhoA controls rear-edge ﬁlopodia
retraction and cell contraction (Theveneau and Mayor, 2013).
Cadherin-binding mediated signaling through a variety of ad-
herens junction accessory proteins coordinate RhoA and Rac1
expression proteins to promote efﬁcient collision driven collective
migration requiring both co-attraction and contact inhibited lo-
comotion (Kashef et al., 2009; Niessen et al., 2011). Restoration of
the constitutively active (CA), but not dominant-negative, form of
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mation (Kashef et al., 2009). In our application, expression of CA-
RhoA was sufﬁcient to restore stress ﬁber formation, ﬁlopodia
extension, and ECM gene expression, supporting that RhoA acts
downstream of Cad-11 to coordinate sensation into migratory re-
sponses. This is not to say that other GTPase activities could be
involved. For example, RAC1 has also been shown to rescue de-
creases in migration ability due to loss of Cad-11 in neural crest
cells (Theveneau et al., 2010). Cad-11 binding mediates these ac-
tivities through its interaction with RhoA/Rac1 at P120 or through
competition with Wnt/PCP signaling by sequestering β-catenin
(Boguslavsky et al., 2007; Rimm et al., 1995). Indeed, cell polarity is
disrupted by either Cad-11 deﬁciency or overexpression of Wnt
signaling via constitutively activating disheveled, and is rescued by
forced activation of RhoA or Rac1 (Koehler et al., 2013). GTPase
activity is further modiﬁed by integrin mediated focal adhesion
complex proteins to migrate and remodel matrix, including ﬁla-
minA, FilGAP, and CdGAP (Duval et al., 2014; LaLonde et al., 2006;
Ohta et al., 2006). Importantly, small GTPase signaling interacts
with known valvulogenic signaling pathways, including TGFβ and
Wnt/β-catenin (Chen et al., 2011; Mercado-Pimentel et al., 2007).
More likely a complex dynamic of cell–cell and cell-matrix adhe-
sion coordinates formation and stabilization of the endocardial
cushion, and assessing the speciﬁc roles of each is an important
remaining question.
Cellular compaction of the endocardial cushions is critical for
fetal valve remodeling to create thin, ﬁbrous leaﬂets that prevent
regurgitation under increasing hemodynamic loads (Phoon et al.,
2004). Ultrasound determined that the aortic valves of Cad-11  /
fetal mice were mechanically insufﬁcient, and histology conﬁrmed
the tissue was markedly thickened. We veriﬁed the inability of
aortic valve mesenchyme to compact 3D matrix after Cad-11
knockdown, which supports that the functional capacity of valves
to remodel is severely diminished post-EMT. The mechanism for
this deﬁciency is not yet fully elucidated, but evidence suggests a
role for impaired mechanosensation, potentially via RhoA. We
previously showed Rho kinase inhibition disrupts 3D matrix
compaction of atrioventricular mesenchymal cells (Butcher et al.,
2007a). Activation of RhoA by LPA induced cushion stiffening and
ECM deposition, while rho kinase blockade inhibited both (Tan
et al., 2013). Cad-11 signaling may also affect interact with other
signaling programs, one example of which could be TGFβ. We
recently showed that exogenous TGFβ3 induces atrioventricular
cushion stiffening while limiting its compaction (Buskohl et al.,
2012). Similarly, Hutcheson et al. (2013) determined TGFβ1 sti-
mulation increased cellular tension and Cad-11 expression in adult
aortic valve interstitial cells. Cad-11 withstands 2x the dissociation
force of N-cadherin (another important mesenchymal cadherin),
and requires much lower calcium concentrations to act (Pittet
et al., 2008). Conversely, Cad-11 expression decreases in the in-
terstitium during normal fetal valve remodeling but is maintained
in the endothelium, which indicates that Cad-11 may exhibit dif-
ferent functions within each cell type during valvular morpho-
genesis (Zhou et al., 2013).
The function of Cad-11 in postnatal valve homeostasis remains
largely unknown. Cad-11 expression is restricted to the en-
dothelium in healthy valves, but is reactivated in the interstitium
during calciﬁc degeneration. TGFβ mediated Cad-11 expression
coordinates valve interstitial cell aggregation and nodule forma-
tion in vitro through increased cell–cell tension (Hutcheson et al.,
2013), but whether this progresses to calciﬁcation remains unclear
(Cloyd et al., 2012). We found in this study that the few postnatal
Cad-11  / survivors maintained persistently thickened aortic
valves, but relatively normal proportions of ECM expression. These
valves had decreased RhoA activity, but normal Sox9 expression
compared to wildtype controls. Interestingly, the adult valves wereno longer regurgitant, but hemodynamically stenotic. Further-
more, we found a few small calciﬁc lesions in 10 month wildtype
valves, but none were found in Cad-11  / aortic valves. These
ﬁndings suggest that the lack of Cad-11 still compromises the
ability of postnatal valves to properly sense their mechanical en-
vironment and remodel the tissue accordingly, but manages to
avoid calciﬁc degeneration. Cad-11 therefore exerts multiple in-
ﬂuences on resident cell behavior, including cell contractile phe-
notype, sensation of external microenvironment, and production/
maturation of extracellular matrix. The mechanism for this is not
yet elucidated, but may be related to impaired cellular mechan-
osensation. We previously identiﬁed Cad-11 as uniquely expressed
in valve endothelium and was shear stress sensitive (Butcher et al.,
2006), but valves also experience cyclic stretch and pressure loads.
Given the strong relationship between valve morphology and
function, our results suggest that well controlled mechanical sig-
naling and feedback response is essential for maintenance of aortic
valve tissue homeostasis. Indeed, mechanical conditioning of de
novo engineered valve tissues induces mechanical strengthening
and biological maturation, both of which are predictive of in vivo
performance (Rabkin-Aikawa et al., 2004).5. Conclusions
In this study, we establish essential roles for Cad-11 for col-
lective migration of mesenchymal progenitors in forming the en-
docardial cushion and its subsequent compaction into thin ﬁbrous
leaﬂets. We also identiﬁed RhoA activity downstream of Cad-11 as
sufﬁcient to control the migratory and traction force generation for
these morphogenic behaviors. Finally, we determined that lack of
Cad-11 results in persistently malformed valves, but protection
from calciﬁcation. These results support that Cad-11 is an im-
portant mechanosensory component regulating heart valve mor-
phogenesis and tissue homeostasis, misexpression of which leads
to congenital and postnatal valve dysfunction.Acknowledgments
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